Start an analysis for SILO
Silo Pharma, Inc.
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $1m | 30-Sep-26 | 10-Q filed 13-Nov-26 |
| Remaining authorization | $927.5k | 30-Sep-26 | 10-Q filed 13-Nov-26 |
| Program expiry | 31-Dec-26 | 30-Sep-26 | 10-Q filed 13-Nov-26 |
| Repurchased last quarter | $72.5k | 30-Sep-26 | 10-Q filed 13-Nov-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 20-Feb-26 | $1m | $927.5k | 31-Dec-26 | Board of Directors authorized a stock repurchase plan to repurchase up to $1,000,000 of our issued and outstanding common stock, from time to time, with such program to be in place until December 31, 2026.10-Q filed 13-Nov-26 |
Open-market repurchases
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 30-Sep-26 | 16,873 | $2.05 | $34.6k | 10-Q filed 13-Nov-26 |
| 31-Aug-26 | 3,670 | $2.77 | $10.2k | 10-Q filed 13-Nov-26 |
| 31-Jul-26 | 6,015 | $4.61 | $27.7k | 10-Q filed 13-Nov-26 |